Skip to main content

entyvio.com

entyvio.com had about 426.56K visits in September 2026, up 27.27% from August; most traffic is social.

ENTYVIO® (vedolizumab) for Crohn's Disease or Ulcerative Colitis

Website traffic

How much traffic does entyvio.com get?

426.56K

+27.27%MoMEstimated monthly visits
789460.68K307.12K153.56K0
Global rank

148,244

Country rank · United States

30,023

Category rank · Pharmacy

63

Average visit duration

00:38

Pages per visit

1.24

Bounce rate

83.46%

Domain age

15 years

Search share

1.7%

Sources

Where does entyvio.com's traffic come from?

  • Social
    64.6%
  • Display ads
    13.6%
  • Paid search
    12.8%
  • Direct
    6.5%
  • Search
    1.7%
  • Referrals
    0.6%
  • Email
    0.2%
  • Generative AI
    0.1%
  • Other
    0.0%

Regions

Which countries visit entyvio.com?

  • United States
    92.4%
  • Canada
    3.2%
  • United Kingdom
    1.7%
  • India
    1.3%
  • Germany
    0.8%

See how entyvio.com compares with the most visited websites in the world, the fastest growing websites and sites gaining organic search traffic.

Search visibility

What keywords send traffic to entyvio.com?

Keyword samples

Estimated visitsMonthly searchesVisits ÷ searches
  1. entyvioBRAND9805.79K17%
  2. crohn's disease570156.33K0%
  3. colitis dieta alimenticia380—
  4. how many kinds of colitis there are still380—
  5. entyvio infusion what is the concern with soresBRAND33035094%

Keyword rankings

Keyword rankings

Example · google.comUnited States · English

86.4M

Search estimate

New 1 · Up 2

Ranking keywords
12,400
Landing pages
4
Search competitors
4
AI citations
2
PositionEstimated visits
  1. google#142M
  2. gmail#118.2M
  3. google maps#19.4M
  4. google drive#14.1M

Full keyword rankings are a Pro feature

Unlock Pro

Baidu rank

Site profile

What does entyvio.com show publicly?

  • HTTP 200
  • Email authentication
  • Hosting ASN
HTTP
200
Page size
55.7 KiB
Hosting
FASTLY · AS54113
Email authentication
SPF · DMARC reject
TLS
TLSv1.3 · 55 days
Page and SEO
Title
ENTYVIO® (vedolizumab) for Crohn's Disease or Ulcerative Colitis
Description
ENTYVIO is a biologic treatment for moderate to severe Crohn's disease (CD) or ulcerative colitis (UC). See Safety and Prescribing Information.
Cross-origin redirect
Yes
Word count
1,647
Internal / external links
6 / 11
Canonical
https://www.entyvio.com/
Language
en-US
H1 / H2
1 / 2
Images missing alt
2 / 7
OG / Twitter
OG
Technology and tracking1 tracking
Technology clues
jQuery · React
Tracking clues
Google Tag Manager
External script hosts
cdn.cookielaw.org · assets.adobedtm.com
Security headers
3 / 6
HSTS / CSP
HSTS
Email and DNS securitySet
SPF
Set
DMARC
Set · reject
DKIM selectors
Not found
IPv6
No AAAA
SOA
ns-1583.awsdns-05.co.uk
NS
ns-1041.awsdns-02.org. · ns-1583.awsdns-05.co.uk. · ns-396.awsdns-49.com. · 1 more
MX
10 inbound-smtp.us-east-1.amazonaws.com.
Hosting and networkAS54113
A
151.101.3.10 · 151.101.131.10 · 151.101.67.10 · 151.101.195.10
Hosting ASN
AS54113 · 151.101.0.0/22
Hosting organization
FASTLY - Fastly, Inc.
Hosting country
US
BGP announcement
Yes
TLS
TLSv1.3 · Verified
Certificate issuer
YR2
Certificate remaining
55 days
Certificate SAN
DNS:entyvio.com · DNS:www.entyvio.com
robots and AI crawlingHTTP 200
Robots.txt
200
Global Disallow /
No
Sitemap
URL set · 4
AI explicitly disallowed
0
AI explicitly allowed
16
Well-known public paths
Present / checked
0 / 5

Website information

When was entyvio.com registered?

Domain
entyvio.com
Registration status
Domain registered
Registered
2011-07-12
Registrar
CSC Corporate Domains, Inc.
Expires
2027-07-12
Domain age
15 years
DNSSEC
No
Registry status
client transfer prohibited

Similar sites

What sites are similar to entyvio.com?

What's in this report

The report starts with a whole-site monthly visit estimate. Search visibility and public site facts follow when they exist.

  • Website traffic is a modeled whole-site estimate, with a source, observation period and confidence.
  • Search visibility is ranking keywords and search traffic, listed separately from whole-site visits.
  • Missing or partial values stay marked in the report.